PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 119 filers reported holding PTC THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $2,087,000 | -44.5% | 55,935 | -40.8% | 0.00% | -50.0% |
| Q4 2021 | $3,760,000 | +16.3% | 94,410 | +8.7% | 0.00% | 0.0% |
| Q3 2021 | $3,232,000 | +6.3% | 86,862 | +20.7% | 0.00% | 0.0% |
| Q2 2021 | $3,041,000 | +0.7% | 71,948 | +12.8% | 0.00% | 0.0% |
| Q1 2021 | $3,020,000 | -9.6% | 63,771 | +16.5% | 0.00% | 0.0% |
| Q4 2020 | $3,340,000 | +43.9% | 54,728 | +10.2% | 0.00% | 0.0% |
| Q3 2020 | $2,321,000 | +3.6% | 49,641 | +12.4% | 0.00% | 0.0% |
| Q2 2020 | $2,241,000 | +10.8% | 44,161 | -2.6% | 0.00% | 0.0% |
| Q1 2020 | $2,023,000 | +9.7% | 45,343 | +18.1% | 0.00% | +100.0% |
| Q4 2019 | $1,844,000 | +46.1% | 38,394 | +2.9% | 0.00% | 0.0% |
| Q3 2019 | $1,262,000 | -16.8% | 37,328 | +10.7% | 0.00% | 0.0% |
| Q2 2019 | $1,517,000 | -2.9% | 33,708 | -18.8% | 0.00% | 0.0% |
| Q1 2019 | $1,563,000 | +7.3% | 41,522 | -2.1% | 0.00% | 0.0% |
| Q4 2018 | $1,456,000 | +17.4% | 42,420 | +60.7% | 0.00% | 0.0% |
| Q3 2018 | $1,240,000 | +32.3% | 26,391 | -5.0% | 0.00% | 0.0% |
| Q2 2018 | $937,000 | +28.0% | 27,789 | +2.7% | 0.00% | 0.0% |
| Q1 2018 | $732,000 | +61.9% | 27,069 | -0.2% | 0.00% | – |
| Q4 2017 | $452,000 | -15.5% | 27,120 | +1.4% | 0.00% | -100.0% |
| Q3 2017 | $535,000 | -39.2% | 26,739 | -44.3% | 0.00% | 0.0% |
| Q2 2017 | $880,000 | +122.2% | 48,004 | +19.4% | 0.00% | 0.0% |
| Q1 2017 | $396,000 | -56.1% | 40,216 | -51.4% | 0.00% | 0.0% |
| Q4 2016 | $902,000 | +47.4% | 82,673 | +89.3% | 0.00% | 0.0% |
| Q3 2016 | $612,000 | +64.1% | 43,677 | -17.9% | 0.00% | 0.0% |
| Q2 2016 | $373,000 | +203.3% | 53,184 | +178.9% | 0.00% | – |
| Q1 2016 | $123,000 | -98.1% | 19,072 | -90.3% | 0.00% | -100.0% |
| Q4 2015 | $6,380,000 | +1186.3% | 196,918 | +960.5% | 0.01% | +1000.0% |
| Q3 2015 | $496,000 | -29.7% | 18,569 | +26.6% | 0.00% | 0.0% |
| Q2 2015 | $706,000 | -6.7% | 14,665 | +17.9% | 0.00% | -50.0% |
| Q1 2015 | $757,000 | +23.3% | 12,439 | +4.9% | 0.00% | +100.0% |
| Q4 2014 | $614,000 | +27.4% | 11,860 | +8.3% | 0.00% | 0.0% |
| Q3 2014 | $482,000 | – | 10,955 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |